NO20051847L - Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi. - Google Patents
Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi.Info
- Publication number
- NO20051847L NO20051847L NO20051847A NO20051847A NO20051847L NO 20051847 L NO20051847 L NO 20051847L NO 20051847 A NO20051847 A NO 20051847A NO 20051847 A NO20051847 A NO 20051847A NO 20051847 L NO20051847 L NO 20051847L
- Authority
- NO
- Norway
- Prior art keywords
- neurosis
- bulimia
- anorexia
- epa
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Eikosapentaensyre (EPA) anvendes i behandlingen av anoreksia nevrosa, bulimi og relaterte kliniske syndromer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0221480.7A GB0221480D0 (en) | 2002-09-16 | 2002-09-16 | Treatment of anorexia nervosa (AN) and bulimia |
PCT/GB2003/003985 WO2004024136A1 (en) | 2002-09-16 | 2003-09-16 | Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051847L true NO20051847L (no) | 2005-04-15 |
Family
ID=9944164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051847A NO20051847L (no) | 2002-09-16 | 2005-04-15 | Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi. |
Country Status (20)
Country | Link |
---|---|
US (1) | US20060135608A1 (no) |
EP (1) | EP1556028A1 (no) |
JP (1) | JP2006503031A (no) |
KR (1) | KR20050042823A (no) |
CN (1) | CN1694694A (no) |
AU (1) | AU2003269138A1 (no) |
BR (1) | BR0317857A (no) |
CA (1) | CA2499142A1 (no) |
GB (1) | GB0221480D0 (no) |
HR (1) | HRP20050245A2 (no) |
IS (1) | IS7744A (no) |
MX (1) | MXPA05002943A (no) |
NO (1) | NO20051847L (no) |
NZ (1) | NZ538793A (no) |
PL (1) | PL375726A1 (no) |
RS (1) | RS20050226A (no) |
RU (1) | RU2330653C2 (no) |
TW (1) | TW200410682A (no) |
WO (1) | WO2004024136A1 (no) |
ZA (1) | ZA200502161B (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003048831A (ja) | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
WO2005046668A1 (ja) * | 2003-11-14 | 2005-05-26 | Mochida Pharmaceutical Co., Ltd. | 言語障害予防・治療剤 |
JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
JP5967855B2 (ja) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
KR101430214B1 (ko) | 2006-12-28 | 2014-08-18 | 산토리 홀딩스 가부시키가이샤 | 신경 재생제 |
US8816110B2 (en) | 2007-02-15 | 2014-08-26 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
ES2561482T3 (es) | 2007-02-15 | 2016-02-26 | Centre De Recherche Sur Les Biotechnologies Marine | Monoglicéridos de ácido graso poliinsaturado, derivados, y sus usos |
WO2008113177A1 (en) | 2007-03-20 | 2008-09-25 | Centre De Recherche Sur Les Biotechnologies Marines | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
SG10201708952TA (en) * | 2009-06-15 | 2017-12-28 | Ian Osterloh | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
BR112013020346A2 (pt) * | 2011-02-11 | 2019-09-24 | Du Pont | concentrado de ácido eicosapentaenoico, produto farmac~eutico, método de elaboração de um concentrado de ácido eicosapentaenoico e uso de óleo microbiano |
US9447020B2 (en) | 2013-10-31 | 2016-09-20 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
RU2545988C1 (ru) * | 2013-11-12 | 2015-04-10 | Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы | Способ лечения хронического запора и функциональной анорексии |
AU2019217673A1 (en) | 2018-02-07 | 2020-09-24 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
US20210130897A1 (en) * | 2018-04-16 | 2021-05-06 | Quadrant Biosciences Inc. | Salivary microrna levels in anorexia nervosa provide a liquid biopsy of metabolic and neuropsychiatric status |
CA3054203C (en) | 2018-05-03 | 2021-01-05 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
CN109276262B (zh) * | 2018-07-30 | 2021-01-26 | 中国科学院心理研究所 | 一种用于筛选高危进食障碍的检测系统 |
WO2021195627A1 (en) * | 2020-03-27 | 2021-09-30 | Homeostasis Therapeutics, Limited | Method of treatment for anorexia nervosa, bulimia and related clinical syndromes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
-
2002
- 2002-09-16 GB GBGB0221480.7A patent/GB0221480D0/en not_active Ceased
-
2003
- 2003-09-16 MX MXPA05002943A patent/MXPA05002943A/es not_active Application Discontinuation
- 2003-09-16 EP EP03750919A patent/EP1556028A1/en not_active Ceased
- 2003-09-16 CA CA002499142A patent/CA2499142A1/en not_active Abandoned
- 2003-09-16 NZ NZ538793A patent/NZ538793A/en unknown
- 2003-09-16 AU AU2003269138A patent/AU2003269138A1/en not_active Abandoned
- 2003-09-16 RU RU2005107416/14A patent/RU2330653C2/ru not_active IP Right Cessation
- 2003-09-16 JP JP2004535695A patent/JP2006503031A/ja active Pending
- 2003-09-16 RS YUP-2005/0226A patent/RS20050226A/sr unknown
- 2003-09-16 US US10/528,114 patent/US20060135608A1/en not_active Abandoned
- 2003-09-16 KR KR1020057004483A patent/KR20050042823A/ko not_active Application Discontinuation
- 2003-09-16 TW TW092125483A patent/TW200410682A/zh unknown
- 2003-09-16 WO PCT/GB2003/003985 patent/WO2004024136A1/en active Application Filing
- 2003-09-16 BR BR0317857-9A patent/BR0317857A/pt not_active IP Right Cessation
- 2003-09-16 CN CNA038251698A patent/CN1694694A/zh active Pending
- 2003-09-16 PL PL03375726A patent/PL375726A1/xx not_active Application Discontinuation
-
2005
- 2005-03-15 IS IS7744A patent/IS7744A/is unknown
- 2005-03-15 ZA ZA200502161A patent/ZA200502161B/en unknown
- 2005-03-16 HR HR20050245A patent/HRP20050245A2/hr not_active Application Discontinuation
- 2005-04-15 NO NO20051847A patent/NO20051847L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20060135608A1 (en) | 2006-06-22 |
IS7744A (is) | 2005-03-15 |
RU2005107416A (ru) | 2006-01-20 |
EP1556028A1 (en) | 2005-07-27 |
CA2499142A1 (en) | 2004-03-25 |
TW200410682A (en) | 2004-07-01 |
RU2330653C2 (ru) | 2008-08-10 |
PL375726A1 (en) | 2005-12-12 |
HRP20050245A2 (en) | 2005-10-31 |
JP2006503031A (ja) | 2006-01-26 |
BR0317857A (pt) | 2005-12-06 |
KR20050042823A (ko) | 2005-05-10 |
NZ538793A (en) | 2007-05-31 |
RS20050226A (en) | 2007-09-21 |
CN1694694A (zh) | 2005-11-09 |
MXPA05002943A (es) | 2005-06-03 |
ZA200502161B (en) | 2005-09-15 |
WO2004024136A1 (en) | 2004-03-25 |
AU2003269138A1 (en) | 2004-04-30 |
GB0221480D0 (en) | 2002-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051847L (no) | Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi. | |
NO20061736L (no) | Krystallform av epotilon B | |
ATE423559T1 (de) | Kombinationstherapie durch glukoseresorptionshemmer und ppar modulatoren | |
PL374865A1 (en) | Treatment of tnf alpha related disorders | |
HK1076541A1 (en) | Electro-osmotic pumps and micro-channels | |
DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
DK2298338T3 (da) | Lactoferrin-sammensætninger og fremgangsmåder til behandling af hudsår | |
SE0102315D0 (sv) | Compounds | |
MY142777A (en) | Substituted indole-o-glucosides | |
BRPI0413449A (pt) | compostos de quinoxalina | |
UA87991C2 (en) | Substituted indole-o-glucosides | |
NO20055741L (no) | Nye kjemiske forbindelser | |
NO20056161L (no) | Formuleringer for behandling av artrittilstander | |
IS7858A (is) | Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD) | |
NO20071378L (no) | Tiazolo-naftylsyrer. | |
MXPA02007099A (es) | Compuestos de tiazola, imidazola y oxazola y tratamientos de desordenes asociados con la maduracion de la proteina. | |
NO20024240D0 (no) | Nye arylfruktose-1,6-bisfosfataseinhibitorer | |
ATE312096T1 (de) | Neue verbindungen | |
BR0315644A (pt) | Piperazinil e diazapanil benzamidas e benzotioamidas | |
EA200601589A1 (ru) | Производные 7h-8,9-дигидропирано-(2,3-c)имидазо(1,2a)пиридина и их применение в качестве ингибиторов секреции кислоты желудочного сока | |
SE0302304D0 (sv) | Novel compounds | |
NO20010860L (no) | Nye forbindelser | |
PT1419163E (pt) | Imidazopiridinas triciclicas | |
DE60305522D1 (de) | Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer | |
ATE417856T1 (de) | Motilidverbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |